PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F23Y9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $20,896
Award facts
- Contract value 100% obligated
- $20,895.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $20,895.86, was awarded on September 1, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery through the Defense Logistics Agency's Medical Supply Chain. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability in fulfilling complex medical supply requirements across multiple therapeutic domains, including specialty medications, diabetes treatments, neurological pharmaceuticals, pain management drugs, antibiotics, and medical devices. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among select contractors capable of meeting the federal government's strategic pharmaceutical supply requirements.
Quick answers
Who was awarded contract SPE2D825F23Y9?
SPE2D825F23Y9 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 1, 2025.
How much is contract SPE2D825F23Y9 worth?
The government has obligated $20,896 on SPE2D825F23Y9.
Is contract SPE2D825F23Y9 an order under another contract?
Yes. SPE2D825F23Y9 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D825F23Y9 competed?
The extent of competition for SPE2D825F23Y9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award